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Pain, agitation, and behavioural problems in people
with dementia admitted to general hospital wards:
a longitudinal cohort study
Elizabeth L. Sampsona,b,*, Nicola Whitea, Kathryn Lorda, Baptiste Leurenta, Victoria Vickerstaffa, Sharon Scotta,
Louise Jonesa
Abstract
Pain is underdetected and undertreated in people with dementia. We aimed to investigate the prevalence of pain in people with dementia
admitted to general hospitals and explore the association between pain and behavioural and psychiatric symptoms of dementia (BPSD).
We conducted a longitudinal cohort study of 230 people, aged above 70, with dementia and unplanned medical admissions to 2 UK
hospitals. Participantswere assessedat baseline andevery 4days for self-reportedpain (yes/noquestion andFACESscale) andobserved
pain (PainAssessment inAdvancedDementia scale [PAINAD]) atmovement andat rest, for agitation (Cohen–MansfieldAgitating Inventory
[CMAI]) and BPSD (Behavioural Pathology in Alzheimer Disease Scale [BEHAVE-AD]). On admission, 27% of participants self-reported
pain rising to 39% on at least 1 occasion during admission. Half of them were able to complete the FACES scale, this proportion
decreasingwithmore severedementia.Using thePAINAD,19%hadpain at rest and57%hadpain onmovement onat least 1occasion (in
16%, this was persistent throughout the admission). In controlled analyses, pain was not associated with CMAI scores but was strongly
associated with total BEHAVE-AD scores, both when pain was assessed on movement (b5 0.20, 95% confidence interval [CI]5 0.07-
0.32, P5 0.002) and at rest (b5 0.41, 95% CI5 0.14-0.69, P5 0.003). The association was the strongest for aggression and anxiety.
Pain was common in people with dementia admitted to the acute hospital and associated with BPSD. Improved pain management may
reduce distressing behaviours and improve the quality of hospital care for people with dementia.
Keywords: Pain, Dementia, Behavioural problems, Agitation, General hospital
1. Introduction
Pain is commonly underdetected and undertreated in people
with dementia20,34,47 who may be unable to understand37 or
verbalise44 that they are in pain. Previous studies have focussed on
community samples and care home residents49,54 and have found
that pain affects up to half of people with dementia in these
settings.48,52 Little attention has been given to pain in people with
dementia in the general hospital, despite the fact that dementia is
common in older hospital inpatients, with a prevalence on medical
wards of around40%.33,42 Identifyingpain in peoplewith dementia is
vital because poor pain recognition and management slows
recovery, increases functional decline, and may be associated with
behavioural and psychiatric symptoms of dementia (BPSD).22,44
These symptoms are common and affect up to 85% of people
with dementia over a 5-year period.51 They comprise a range of
problems including agitation, psychotic symptoms (hallucinations
and delusions), wandering, aggression, mood disturbance, and
apathy. Agitation is a particularly distressing symptom, which has
been defined as “inappropriate verbal, vocal, ormotor activity that
is not judged by an outside observer to result directly from the
need or confusion of the individual”11 and includes behaviours
such as screaming, hitting, and pacing. However, causes of
BPSD are often complex, multifactorial, and associated with
genetic factors, neurodegenerative changes, and unmet needs,
such as unrecognized pain.31 Psychiatric symptoms of dementia
significantly increase costs of care,36 decrease quality of life of the
person with dementia,21 and increase caregiver burden and
depression.9
A number of recent studies have examined the association
between pain and BPSD.22,26,54 When in pain, a person with
dementia may respond with agitation, resistiveness to care,
depression, or withdrawal.41,54 This association is, however,
complex. Someobservational pain scales are sensitive in detecting
pain in peoplewith dementia but have a high false-positive rate and
may actually detect changes in behaviour caused by fear,
frustration, or anger.28 In the general hospital, other factors such
as delirium and the confusing ward environment may increase the
risk of BPSD occurring2 andmake the detection andmanagement
of pain more challenging.
It is not clear whether particular types of BPSD are more likely to
be associated with pain in the general hospital setting. Studies
conducted in care homes have found socially inappropriate
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behaviour, resisting care, delusions, and reduced wandering are
significantly associated,54 whereas others have identified aggres-
sion and agitation as being strongly associated with pain.1 A first
step in improving the identification and management of pain in
peoplewith dementia in general hospitals is to identify its prevalence
and understand the key clinical and behavioural associations.
Our aim was to define the prevalence of pain using self-rated
and observational pain scales in people with dementia in the
general hospital. We also wished to examine demographic and
clinical factors associated with pain in this population and to
explore a hypothesised association between pain and BPSD,
including agitation in this setting.
2. Methods
This longitudinal cohort study was conducted in 2 large acute
general hospitals in London, United Kingdom. Both cover a wide
area encompassing socioeconomic and ethnic diversity, serving
a combined population of 2 million people.
2.1. Participants
Two research assistants spent 5 months at each site (4th April
2011 until 6th March 2012), assessing within 72 hours of
admission, all patients admitted with any type of medical problem
under the care of geriatricians. Clinical staff identified patients
who met the inclusion criteria:
(1) Age 70 years or above with an unplanned acute medical
admission
(2) Able to give written informed consent or with an informal carer
or “professional consultee” available to give agreement for the
person to participate
(3) Abbreviated Mental Test Score (AMTS19) of #7/10 (routinely
measured on admission).
We excluded patients who indicated verbally or nonverbally
that they did not wish to participate, were moribund, or non-
English speaking.
Potential participants were screened for delirium using the
Confusion Assessment Method (CAM).25 Those who were not
delirious were consented or agreement was obtained from
a carer and assessed using the Mini Mental State Examination
(MMSE).16 If they scored #24, they entered the study. Patients
with initial delirium were rescreened 48 hours later, if this
resolved, we completed the MMSE. If delirium was persistent,
patients were ineligible as we could not establish a clear
dementia diagnosis. However, those with delirium who already
had a documented specialist dementia diagnosis (neurology,
geriatrics, old age psychiatry) were eligible. Dementia diagnosis
was confirmed using a structured clinical assessment based on
operationalised DSM-IV criteria,3 comprising cognitive testing
(MMSE), structured notes review, and discussion with family
and the clinical team.
2.2. Study measures
Dementia severity was measured using the Functional Assess-
ment Staging Scale (FAST).39 Presenting medical problem at
admission, Charlson Co-morbidity Score,7 Waterlow score,57
and demographics were obtained from medical notes. Drug
charts were examined at baseline and at every study visit for the
prescription of analgesics, we documented the type of drug and
whether it was prescribed on a regular or “as-required” basis.
The Pain Assessment in Advanced Dementia scale (PAINAD)
was rated first.56 This observational tool comprises 5 domains
(breathing, negative vocalisations, facial expression, body lan-
guage, and consolability) each scored by severity from 0 to 2
points (maximum 10). Pain was observed during movement (care
task such as repositioning in bed or standing from chair) and at
rest. Assessors received training in the use of all tools and
interrater reliability for the PAINAD for 35 random cases at rest
ranged from 94.3% to 100% (k 5 0.64-1.00), and at movement
85.3% to 97.1% (k 5 0.64-0.84). A cutoff of $2 on the PAINAD
was used to indicate the presence of pain.58
For self-reported pain, participants were shown and read a piece
of paper printed in large type with the question “Are you in pain?”
They were asked to answer “yes” or “no” or indicate these
responses by pointing at the paper. They were then shown the
Wong-Baker FACES scale, line drawings of 7 faces indicating
increasing amounts of pain.18
After pain assessment, agitation was assessed by a different
research assistant. The Cohen–Mansfield Agitation Inventory
(CMAI) is a scale describing 29 agitated behaviours, each of
which is rated on a 7-point frequency scale, from 1 indicating not
present to 7 indicating several times an hour.10 The range is from
29 to 203 with a cutoff score of 39 and above indicating clinically
significant agitation.4
We also used the Behavioural Pathology in Alzheimer Disease
Scale (BEHAVE-AD).40 This rates 7 domains: paranoid and
delusional ideation, hallucinations, activity disturbances, aggres-
siveness, diurnal rhythm disturbance, affective disturbance, and
anxieties and phobias. Scores are generated for the presence or
absence (0/1) and severity of symptoms (05 none, 15mild, 25
moderate, and 3 5 severe) (maximum score 5 75). To complete
the CMAI and the BEHAVE-AD, we observed the participants and
gathered information froma range of sources includingdiscussions
with families, ward staff, and hospital notes. Data were collected at
study entry and then every 4 (61) days for pain and BPSD, until
discharge, death, or “awaiting placement” in a care home.
2.3. Sample size
We could not find any previous studies of pain prevalence in
people with dementia in acute medical wards. Using a predicted
prevalence of pain of 55% from a care home sample of people
with dementia,50 we calculated that 250 participants would
ensure a 95% confidence interval for pain prevalence with 6%
precision. For our analyses exploring the association between
pain and agitation, we took data from a study of pain in people
with dementia that used theCMAI.49 To analyse the hypothesised
association between pain and BPSD, we use repeated measures
(every 4 6 1 days). Power depends on the correlation between
measurements, which we are unable to predict. We can calculate
a conservative estimate by considering a perfect correlation
between repeatedmeasurements (r5 1). Shega et al.49 reported
a mean CMAI score of 50.5 and 42.5 in patients with and
without pain, respectively (standard deviation 18.9). Assuming
the presence of pain in 55% of our sample,50 the power to detect
a significant difference with 250 patients would be 91%.
2.4. Data analysis
Wecalculatedestimatesof prevalencewith95%confidence intervals
(CI) for pain (self-reported, or observed using PAINAD at rest and on
movement) at study entry, at any time during the admission, and over
all study assessments (n 5 965). Generalised estimating equations
(GEE) were used to compute prevalence and 95% confidence
intervals over all assessments during the admission, to take into
account repeated measurements within participants.
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“Persistent pain” was defined as present in participants who
were assessed 3 or more times (the median number of assess-
ments per participant in this project) if pain was recorded on at
least 75% of their study assessments. We created the variable
“undetected pain” for those in whom we recorded any pain
throughout admission, onmovement or at rest, and no analgesics
were prescribed. If they were prescribed analgesia, this was
defined as “detected pain.”50We tested for associations between
demographic and clinical characteristics of the participants and
the presence of pain during admission using x2 or Fisher’s exact
test, as appropriate.
We examined the association between PAINAD score and
the total CMAI, and then BEHAVE-AD total scores using GEEs
with exchangeable correlation structures and robust standard
errors. For pain during movement, we first examined the crude
association, and then adjusted for potential confounders of the
association between pain and BPSD: age, gender, FAST score,
comorbidity and acute illness (cause of admission), and hospital
site. For comparison, we repeated the fully controlled analysis for
pain at rest. Because delirium is associated with behavioural
disturbance, we repeated this analysis excluding participants
with delirium as a sensitivity analysis.
The association between pain and BPSD measures could occur
because observational pain scales capture symptoms of distress29
ie, there is possible overlap between some items included in both
behavioural and pain scales. Because of the potential overlap in
symptoms used by both scales, we conducted a sensitivity analysis,
whereby a 4-member independent panel examined each item on
the PAINAD and BEHAVE-AD for duplication. All agreed that 3
items were duplicated by the BEHAVE-AD (D16-verbal outbursts,
D17-physical threats, and F20-tearfulness); 3 of 4 raters agreed that
there was duplication on 2 items (C14-pacing and purposeless
activity and F21-depressed mood). The GEEmodels were therefore
repeated with all 5 duplicate items removed.
2.5. Ethical issues
Our consent procedure followed the England and Wales Mental
Capacity Act (2005). If a participant agreed and had capacity, we
obtained written informed consent. If they did not have capacity,
we identified a personal consultee to give agreement. This could
be given verbally over the telephone, and the consultee was
posted an agreement form to sign and return. If forms were not
returned, participants’ data were destroyed. If we could not
contact a personal consultee within 48 hours of screening,
a professional consultee (senior member of a clinical team not
directly involved in research or patient care) gave agreement. See
Ref. 46 for a detailed description.
3. Results
We screened 1612 potential participants (Fig. 1). The most
common reasons for exclusionwereMMSEscore of.24 or AMTS
score .7 or patients being discharged before they could be
assessed. Of 292 assessed, 62 were excluded because they did
not fulfil the inclusion criteria or because carerswhogave telephone
agreement did not return signed forms, giving 230 participants
recruited to the study (117 fromhospital 1 and 113 fromhospital 2).
The median length of admission was 12 days (range, 2-72;
interquartile range [IQR] 7-23) with a median of 3 study assess-
ments per participant (range, 1-20; IQR 2-5). No participants
droppedout during the study. Therewere no significant differences
between participants from hospital sites 1 and 2 with respect to
gender, proportion with a previous dementia diagnosis, usual
residence, or Charlson score. Hospital 1 participants were
significantly older (t 5 22.26, P 5 0.025) and more were of
white British origin (82.0%at hospital 1 vs 69.0%at hospital 2,x25
25.9, P5 0.004). Demographic and clinical features of the cohort
and the frequency of BPSD are given in Table 1.
3.1. Prevalence and detection of pain
Only half of the participants (55.2%) could use the Wong-Baker
FACES pain scale at baseline. Of thosewho could use the FACES
scale, at baseline, 41% rated themselves as “very happy,” 9% as
“hurts just a little bit,” 17% as “hurts a little more,” 17% as “hurts
even more,” 8% as “hurts a whole lot,” and 7% as “hurts as much
as you can imagine.”
Ability to use the FACESpain scale was significantly associated
with dementia severity; 80.2% at FAST stage 3 to 5, 69.2% at
FAST stage 6a-6c, 40.5% at FAST stage 6d-e, and only 3.2% of
those at FAST stage 7 could use the scale (Fisher’s exact test 5
65.2 P , 0.001). Therefore, we did not conduct further analyses
using the FACES scale data.
At baseline assessment, 27.0% of participants self-reported that
theywere in pain.Using thePAINADscale, 9.6%hadpain at rest and
42.4% had pain on movement. Over the whole admission, 38.5%
self-reported pain on at least 1 occasion; and on the PAINAD scale,
18.7% had pain during rest and 57.0% had observed pain during
movement (Table 2). There were 138 participants with 3 or more
assessments. These patients had a mean length of admission of
24.6 days (SD 15.6), a median admission of 19 days (IQR 13-32),
and 15.6% of these had persistent pain on movement.
Few demographic or clinical factors were associated with self-
reported pain, however, pain on movement and at rest was
significantly associated with increasing age, having delirium on
admission, and dying during hospital stay (Table 3).
3.2. Prescription of analgesic medication
Analgesics were prescribed for 174 (76%) participants during
their admission. At the first study assessment (baseline), 70% of
participants were prescribed regular or as-required paracetamol
and 33% regular or as-required opiates (Table 4). During
admission, 18% of participants had changes made to their
analgesia; prescribing of as-required paracetamol and regular
opiates increased. Among those who experienced pain during
admission, 12% were not prescribed analgesics.
3.3. Prevalence of agitation and other psychiatric symptoms
of dementia
The median score on the CMAI, at the first assessment was 31.0
(IQR 29-35). The median CMAI score for all study visits was 30.5
(IQR 29-35), and themean 33.0 (SD 5.5) and 24.8%of participants
scored above the cutoff score (39 and above) indicating they had
clinically significant agitation4 on at least 1 occasion during their
admission. Psychiatric symptoms of dementia were experienced
by 75% of participants during their admission as measured on the
BEHAVE-AD scale, the commonest symptoms being aggression,
activity, and sleep disturbance (Table 1). See Ref. 43 for further
information on the prevalence of BPSD in this population.
3.4. Association between pain, agitation, and other
psychiatric symptoms of dementia
We found no significant association between pain and agitation,
as measured by the CMAI. However, there was significant
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association between the total BEHAVE-AD score and pain at
movement and at rest. This association remained significant after
controlling for age, gender, hospital site, FAST score, Charlson
score, and reason for admission, and also after excluding patients
with delirium (Table 5). For particular BPSD, in controlled
analyses, we found that aggression and phobia or anxiety were
associated with pain at movement and at rest.
On excluding items that overlapped between the PAINAD and
the BEHAVE-AD (see Methods), we found that the association
between Pain and the BEHAVE-AD Scale remained significant in
uncontrolled analysis and in controlled analyses examining pain
at rest (Table 5).
4. Discussion
More than one-third of people with dementia reported pain at
some time during admission, similar to community-dwelling
older people and nursing home residents with dementia
Figure 1. Study recruitment flowchart.
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(22%-33%).27,35,38,54 Pain prevalence rose when assessed by
observation using the PAINAD; 57% had pain on movement at
some time during their admission, and in 16%, this was
persistent, occurring throughout their stay in hospital. This
finding illustrates how self-report may lead to underestimation of
pain in people with dementia and the importance of careful
observation for pain at rest and during movement. Many
participants could not use the FACES pain scale, which is
widely used in UK hospitals; this supports findings from care
homes where only 36% of residents can correctly use self-
assessment pain scales.8
Only older age was associated with increased prevalence of
self-reported and observed pain (on movement and at rest).
Those admitted with “falls, fracture, or pain” or “cardiac” events
had lower pain prevalence. This may occur because clinicians
perceive these to be potentially painful conditions and prescribe
accordingly, but they may not consider “infections” to be painful
conditions. The lack of clear proxy markers or associations with
pain highlights the need for individual detailed pain assessment in
the general hospital.49
The association between pain and BPSD has previously been
demonstrated in care homes1,54 but not in general hospitals.
There was no association with agitated behaviours in general (as
measured by the CMAI), but we did find a consistent association
between total BEHAVE-AD scores, and the BEHAVE-AD sub-
scale scores of aggression and anxiety with pain, both at
movement and at rest.
The literature on whether pain is associated with agitation in
people with dementia is inconsistent. Volicer et al.55 found in
a longitudinal study of 2032 Dutch nursing home residents that
pain was not highly related to agitation and pain scores did not
change in proportion to agitation scores. Other studies have
found an association between agitation (measured on the CMAI)
and pain in community-dwelling people with dementia; for every
1-point increase on the CMAI, there was a 3% increase in the
likelihood of caregivers reporting pain (OR 1.03, 95% CI 5 1.00-
1.06, P 5 0.049).49
There are a number of reasons why these findings are
inconsistent. The mean CMAI score in our population was lower
than that found in other studies in community settings49 or in care
homes.24 Thismay have occurred because our study participants
were unwell, likely to be restricted to bed or chair and thus less
able to express many of the behaviours listed in the CMAI, for
example “pacing” or “trying to get to a different place.” In addition,
“agitation” is a nonspecific and overarching term, and agitation
scales such as the CMAI contain a wide range of items. It may
be that specific types of agitation, such as “constant requests
for attention” or “making strange noises,” are more strongly
associated with pain.12,13
Our finding of a strong association between pain and
aggression, on the BEHAVE-AD, is more consistent with
previous work.1,32 In support of this finding is the fact that pain
severity has been found to be associated with the increasing
frequency of aggressive behaviour.1 It could be argued that
when aggression occurs during movement, this is not just
a reaction to pain but also fear or distress at the movement
intervention itself. However, we found a strong association
between observations of aggressive behaviour, which, on the
BEHAVE-AD scale, includes “verbal outbursts” or “physical
threats or other threatening behaviour” including “unaccus-
tomed use of foul or abusive language” and pain at rest
suggesting that this association is not just caused by resistance
to, or rejection of care.
We also found a strong association between anxiety, as
measured on the BEHAVE-AD and pain, in controlled analyses
and at movement and at rest, and between pain and affective
symptoms at rest. This concurs with the findings from other
studies.23 However, when pain is treated in people with
dementia, although depression scores improve, anxiety does
not.23 The way the BEHAVE-AD scale measures anxiety may
Table 1
Characteristics of 230 older people with dementia and
unplanned acute medical admission.
Demographics Total cohort (N5 230)
N %
Gender
Female 151 66
Male 79 34
Age, y
75-84 85 37
85-94 118 51
951 27 12
Ethnicity
White British 175 76
Black Caribbean 15 7
Other 40 17
Place of residence (n 5 219)
Home 147 67
Residential home 26 12
Nursing home 41 19
Other 5 2
Reason for admission (n 5 229)
Infections: lungs/skin/viral 79 34
Infections: UTI/blocked catheter 36 16
Fall/fracture/pain 31 14
Cardiac 22 10
Other 61 26
FAST score
3-5 (objective functional deficit, difficulties
with activities of daily living)
86 37
6a-6c (help required putting on clothes,
toileting, or bathing)
39 17
6d-6e (urinary and faecal incontinence) 74 32
7a-f (,6 words, can no longer walk, sit up,
smile, hold up head)
31 14
Charlson comorbidity score on admission
0-1 57 25
2-3 124 54
41 49 21
Waterlow score on admission (n 5 174)
0-9 18 10
101 156 90
Delirium on admission (CAM) (n 5 227) 26 11
CMAI score during whole admission (median,
IQR)
31 (29, 35)
BPSD at any point during whole admission
(BEHAVE-AD scale)
Any symptom 172 75
Paranoia/delusions 26 11
Hallucination 34 15
Activity disturbance 101 44
Aggressive 130 56
Sleep disturbance 97 42
Affect 77 34
Phobia/anxiety 81 35
Length of admission (median, IQR), days 12 (7, 23)
Died during hospital admission 30 13
BEHAVE-AD, Behavioural Pathology in Alzheimer Disease Scale; BPSD, behavioural and psychiatric
symptoms of dementia; CAM, Confusion Assessment Method; CMAI, Cohen–Mansfield Agitation Inventory;
FAST, Functional Assessment Staging Scale; IQR, interquartile range; UTI, urinary tract infection.
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have influenced this finding. The anxiety subscale uses non-
specific items that may indicate verbal agitation rather than
diagnose an anxiety syndrome. In studies that use specific and
validated anxiety tools, correlations between anxiety and pain
are less strong.45
We found no significant association between pain and “activity
disturbance”; other studies have also found that the association
between pain and BPSD is stronger for behaviours, which do not
require ambulation and that pain is negatively associated with
behaviours such as wandering.1,54
Table 3
Associations between demographic and clinical characteristics and pain in 230 older people with unplanned acute medical
admission.
Self-reported pain* (%) Pain at rest* (%) Pain on movement* (%)
Absent
(n 5 134)
Present
(n 5 84)
P Absent
(n 5 187)
Present
(n 5 43)
P Absent
(n 5 99)
Present
(n 5 131)
P
Gender 0.834 0.596 0.093
Female 62 38 80 20 39 61
Male 60 40 84 16 51 49
Age, y 0.280 0.034 0.035
75-84 59 41 86 14 41 59
85-94 66 34 82 18 49 51
951 50 50 63 37 22 78
Place of residence 0.526 0.178 0.474
Home 64 36 84 16 46 54
Residential home 48 52 69 31 31 69
Nursing home 61 39 83 17 39 61
Other 67 33 60 40 40 60
Reason for admission (n 5 229) 0.028 0.120 0.169
Infections: lungs/skin/viral 50 50 78 22 37 63
Infections: UTI/blocked catheter 53 47 69 31 33 67
Fall/fracture/pain 71 29 87 13 42 58
Cardiac 82 18 95 5 59 41
Other 67 33 84 16 51 49
FAST score 0.291 0.457 0.185
3-5 (functional deficit, difficulties with
activities of daily living)
62 38 86 14 48 52
6a-6c (help required putting on clothes,
toileting, or bathing)
49 51 82 18 41 59
6d-6e (urinary and faecal incontinence) 67 33 77 23 46 54
7a-f (,6 words, can no longer walk, sit up,
smile, hold up head)
67 33 77 23 26 74
Charlson comorbidity score 0.222 0.556 0.209
0-1 52 48 77 23 37 63
2-3 64 36 82 18 48 52
41 68 32 86 14 37 63
Waterlow score 0.587 0.744 0.142
0-9 56 44 89 11 61 39
101 62 38 81 19 43 57
Delirium on admission (CAM) 0.247 0.003 0.010
Yes 50 50 58 42 19 81
No 63 37 84 16 46 54
Died during hospital admission 56 44 0.550 60 40 0.004 17 83 0.002
* As found at least once during admission, P values calculated from x2 or Fisher’s exact test.
CAM, Confusion Assessment Method; FAST, Functional Assessment Staging Scale; UTI, urinary tract infection.
Table 2
Prevalence of pain in 230 older people with dementia and unplanned acute medical admission.
Pain Time during admission, number (%)
At baseline, n 5 230 At least once during admission, n 5 230 All assessments n 5 965* Persistent, n 5 138†
Self-reported 54/200 (27.0) 84/218 (38.5) 196/821 (23.9) 8/117 (6.8)
95% CI (20.8, 33.2) (32.0, 45.0) (18.6, 27.5) (2.2, 11.5)
PAINAD scale $2
Pain during rest 22/229 (9.6) 43/230 (18.7) 68/950 (7.2) 0/135 (0.0)
95% CI (5.8, 13.5) (13.6, 23.8) (5.3, 9.8) -
Pain during movement 97/229 (42.4) 131/230 (57.0) 331/946 (35.0) 21/135 (15.6)
95% CI (35.9, 48.8) (50.5, 63.4) (29.4, 39.0) (9.4, 21.7)
* Prevalence for all assessments combined, estimated by generalised estimating equations.
† Defined in the population with 3 or more assessments, as in pain in at least 75% of the occasions.
CI, confidence interval; PAINAD, Pain Assessment in Advanced Dementia scale.
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4.1. Strengths and limitations
It is likely that our cohort was representative and our results can
be generalised.43 The prevalence of dementia and of BPSD are
similar to those reported in other studies in this setting.17,42
Diagnosing dementia in the general hospital is challenging, but is
important as many have not received a previous diagnosis. To
reduce the risk ofmisclassification, we only diagnosed new cases
of dementia in the absence of delirium, screening with the
“maximum sensitivity” version of the CAM.
The acute hospital is a complex research environment, patients
frequently move through wards and staff rotate. We attempted to
overcome reporting bias by gathering information from numerous
sources: family carers, our own observations, and medical and
nursing notes. Recall bias may have led to over-reporting of
“troublesome” behaviours. Our study has the strength of being
based on primary data collection using repeated observations
throughout the whole hospital admission, by trained research
staff. We controlled for a range of potential confounders,
including delirium, but residual confounding may have occurred,
in particular, mood can influence the association between pain
and anxiety.45 We conducted multiple analyses, and some
significant findings may be due to chance.
Observational pain tools have been criticised.29 The PAINAD
has a high false-positive rate in care homes and is highly sensitive
but may have low specificity.28 Thus, our findings may over-
estimate the prevalence of pain. Observational pain tools may
detect distress or other unmet needs caused by constipation or
urinary symptoms or low mood or boredom.29 However, it has
been validated in the general hospital, has high concurrent validity
against self-reported pain,15 has discriminant validity,15 and has
construct validity6; and we found good interrater reliability.43 In
addition, we observed for pain at movement and at rest. The
association between the total BEHAVE-AD score and pain
persisted after sensitivity analysis where we removed items from
the PAINAD that overlapped with those in the BEHAVE-AD scale.
4.2. Clinical implications
There is increasing public concern about the quality of care received
by people with dementia in hospitals; they may be perceived as
“resistive” and “difficult to manage” and prescribed inappropriate
neuroleptic drugs. Some BPSD in the acute hospital may be due to
underdetected and undermanaged pain. This then leads to a cycle
whereby behavioural problems and rejection of care by the person
with dementia can lead to dysfunctional coping in staff,14 increasing
careburdenand furtheralienatingstaff from thepersonwithdementia.
The fact that pain may lead to behavioural disturbance is not
controversial,1 however, it is important to be precise and consider
which specific behaviours are related to pain. This is vital in the
stressful environment of the general hospital where staff may not
have previous knowledge of the personwith dementia. Theremay
be a different behavioural “phenotype” of pain in this setting. Pain
is particularly associated with aggression, even at rest.
Studies have highlighted lack of attention to depression in older
people in hospital.17 Our results suggest that mood may be
a useful indicator of pain in this setting. Antidepressants are not
particularly effective in dementia5; however, a secondary analysis
Table 5
Associations between pain and behavioural and psychiatric symptoms of dementia, using generalised estimating equations in
230 older people with dementia and unplanned acute medical admission.
PAINAD (pain during movement) PAINAD (pain at rest)
Unadjusted (930 observations
on 230 participants)
Adjusted* (928 observations
on 229 participants)
Excluding those with delirium
at baseline* (800 observations
on 200 participants)
Adjusted* (932 observations
on 229 participants)
Coef. 95% CI P Coef. 95% CI P Coef. 95% CI P Coef. 95% CI P
CMAI 0.01 20.00 to 0.03 0.160 0.01 20.00 to 0.03 0.157 0.01 20.01 to 0.02 0.524 0.01 20.01 to 0.04 0.322
Total BEHAVE-AD score 0.21 0.08 to 0.35 0.002 0.20 0.07 to 0.32 0.002 0.17 0.03 to 0.31 0.008 0.41 0.14 to 0.69 0.003
Paranoia/delusions 0.00 20.02 to 0.02 0.970 0.00 20.01 to 0.02 0.997 0.00 20.02 to 0.01 0.605 0.05 20.02 to 0.11 0.181
Hallucination 20.01 20.03 to 0.01 0.209 20.02 20.03 to 0.00 0.115 20.01 20.03 to 0.01 0.082 20.01 20.06 to 0.04 0.747
Activity disturbance 20.02 20.05 to 0.01 0.243 20.02 20.05 to 0.01 0.292 20.02 20.05 to 0.02 0.185 20.01 20.08 to 0.06 0.815
Aggressive 0.17 0.09 to 0.24 <0.001 0.16 0.09 to 0.23 <0.001 0.13 0.05 to 0.20 <0.001 0.16 0.02 to 0.30 0.023
Sleep disturbance 0.01 20.01 to 0.04 0.312 0.01 20.02 to 0.03 0.462 0.01 20.02 to 0.04 0.611 0.02 20.04 to 0.09 0.475
Affect 0.01 20.02 to 0.03 0.716 0.00 20.02 to 0.03 0.799 0.01 20.03 to 0.04 0.794 0.08 0.00 to 0.15 0.047
Phobia/anxiety 0.03 0.00 to 0.07 0.036 0.04 0.01 to 0.07 0.021 0.04 0.01 to 0.08 0.024 0.11 0.04 to 0.17 0.001
BEHAVE-AD scale removing
PAINAD-related items
0.08 0.00 to 0.16 0.043 0.07 20.01 to 0.14 0.069 0.06 20.03 to 0.14 0.177 0.26 0.08 to 0.44 0.005
Results from generalised estimating equations, the coefficients (coef.) represent estimates of the mean difference in CMAI and BPSD score for each 1-point increase on the PAINAD score.
* Adjusted for age, gender, hospital, Functional Assessment Staging category, Charlson score, and the reason for admission.
Bold text indicates significance at ,0.05 level.
BEHAVE-AD, Behavioural Pathology in Alzheimer Disease Scale; CI, confidence interval; CMAI, Cohen–Mansfield Agitating Inventory; PAINAD, Pain Assessment in Advanced Dementia scale.
Table 4
Prescription of analgesia to people with dementia during
acute hospital admission.
At baseline
(n 5 230)
During
admission*
(n 5 185†)
n % n %
Paracetamol
None 68 30 48 26
Regular 103 45 61 33
As required 59 25 76 41
Nonsteroidal anti-inflammatory drugs
None 229 99 184 99
Regular 1 1 0 0
As required 0 0 1 1
Opiates
None 155 67 127 69
Regular 32 14 32 17
As required 43 19 26 14
* Data from any assessments after baseline.
† Forty-three participants had only 1 assessment (at baseline) and 2 had missing data on analgesic
prescribing at follow-up.
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from a randomised controlled trial of pain treatment for BPSD
showed that depressive symptoms significantly improved.23
Thus, improved detection of low mood in general hospitals could
lead to improved pain management.
Enhancing pain assessment does not necessarily improve pain
management.59 We found that although 75% of participants were
prescribed analgesics (mainly paracetamol), persistent pain was
common, suggesting that as-required medication may not have
been given or that pain symptoms may have been difficult to
manage. Nonsteroidal anti-inflammatory drugs (NSAIDs) and
opiates can have severe side effects in older people; NSAIDs have
significant cardiac, gastrointestinal, and renal risks, whereas opiates
can cause delirium and constipation. The clinical challenge is to
balance these risks with those of undertreated pain and the distress
that this can cause. There have been studies to optimise pain
management and decrease BPSD in nursing homes,30 and 1 trial
has shown that behavioural problems, particularly verbal aggres-
sion, are improved by systematic pain management.24 There have
been no studies of such interventions in the general hospital.
However, a number of barriers to improving pain management in
hospitals have been identified, including poor knowledge of how to
manage pain and irregular administration of as-required medica-
tions.53 Improved pain management in hospitals would require
complex interventions that both increase knowledge and facilitate
the use of active implementation strategies.53
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